Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600121658Phase 4Not yet recruiting
Phase 4, randomised trial of thiamine in postoperative delirium (POD) (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Incidence of delirium within 7 days after surgery. Planned start Apr 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600121658.